Reborna Biosciences
Latest round
- Series D
Last raised
- May 2023
Total raised
- $7.1M
Investors
- 6
About Reborna Biosciences
Founded in 2018 in Fujisawa-shi, Japan, Reborna Biosciences, Inc. is focused on innovative therapeutics for rare genetic conditions.Reborna Biosciences, Inc. specializes in the development of innovative therapies targeting genetic rare diseases through its unique drug discovery technology that focuses on low molecular weight drugs with high affinity for ribonucleic acid (RNA). This approach aims to create therapeutics that normalize RNA function, addressing unmet medical needs in conditions often caused by hereditary genetic mutations. The company’s pipeline includes orally administered drugs designed to ease the burden of long-term treatment for patients, thereby improving their quality of life. Reborna's client base primarily consists of healthcare providers and research institutions focused on rare genetic disorders, while end users are patients suffering from these conditions and their families.Reborna Biosciences generates revenue through strategic partnerships and collaborations with healthcare organizations and pharmaceutical companies involved in the treatment of rare diseases. Transactions typically involve B2B agreements where Reborna provides its proprietary drug development services in exchange for milestone payments and royalties based on product commercialization. The revenue structure may include phased payments linked to research and development milestones, as well as ongoing royalties from the sale of therapeutics once they reach the market.In May 2023, Reborna Biosciences, Inc. This investment will enable the company to accelerate the research and development of its pipeline and further enhance its platform. Plans include the development of new therapeutics targeting genetic disorders and expanding into markets across North America, Europe, and parts of Asia by 2024.
Who invested in Reborna Biosciences
6 investors across 2 rounds
See all investors in Reborna Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Reborna Biosciences
Who invested in Reborna Biosciences?
Reborna Biosciences has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Reborna Biosciences raised?
Reborna Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Reborna Biosciences last raise money?
Reborna Biosciences's most recent round on record is a Series D, in May 2023.
What does Reborna Biosciences do?
Founded in 2018 in Fujisawa-shi, Japan, Reborna Biosciences, Inc.
Where is Reborna Biosciences headquartered?
Reborna Biosciences is headquartered in Fujisawa-shi, Japan.
Which VCs invest in companies like Reborna Biosciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Reborna Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Reborna Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.